Paper decisions and execution

Dated journal of decisions, intents, and paper-execution statuses

  1. Oct 26, 2026

    In progress

    CARTBuySatellite · Scanner

    Documentary review does not identify any admissible veto evidence: the frozen evidence bundle is empty. Accordingly, allow the deterministic engine’s already-authorized pullback plan to remain in force without alteratio…

  2. Oct 26, 2026

    In progress

    ARBuySatellite · Scanner

    The quantitative engine has authorized the existing pullback plan; this review finds no admissible documentary basis to suppress it. The plan, risk levels, sizing, and timing remain exclusively those fixed by the determ…

  3. Oct 26, 2026

    In progress

    BRK-B (Berkshire Hathaway)Buy

    No documentary evidence was supplied to support a research-level fundamental conclusion or a permitted veto. The deterministic engine's pullback plan remains immutable and is outside this reviewer's authority; no discre…

  4. Oct 26, 2026

    In progress

    HD (Home Depot)Buy

    Research view is constructive only insofar as the deterministic engine has authorized the candidate; the frozen plan remains the sole execution authority. No documentary veto is supported because the supplied filings co…

  5. Oct 23, 2026

    In progress

    APABuySatellite · Scanner

    Research review does not identify any admissible documentary basis to suppress the deterministic pullback plan: the frozen evidence bundle is empty. The quantitative engine’s authorized plan remains the sole execution i…

  6. Oct 23, 2026

    In progress

    COPBuySatellite · Scanner

    Quantitative engine authorization is intact, with the sole executable plan fixed as a 25% pullback entry at 146.276 and a research-referenced stop at 134.5739. No position should be initiated unless that deterministic t…

  7. Oct 23, 2026

    In progress

    PG (Procter & Gamble)Buy

    The quantitative-primary pullback plan remains the sole executable plan and is not modified by this review. Documentary review identifies no provider-attested, policy-eligible risk requiring suppression; retain the dete…

  8. Oct 23, 2026

    In progress

    WMT (Walmart)Buy

    Maintain a research-only Hold posture: the documentary record does not provide a fundamental thesis sufficient to independently endorse or challenge the quantitative setup. No change to, or authorization of, the immutab…

  9. Oct 15, 2026

    In progress

    WMT (Walmart)Neutral

    The conviction remains positive, but the paper entry was rejected by quality, cost, or risk controls: no position was opened.

  10. Oct 13, 2026

    In progress

    MTSIBuySatellite · Scanner

    No documentary veto is supported because the frozen evidence bundle is empty. The deterministic pullback plan remains the sole executable plan: it is contingent on its pre-set trigger and sizing, with no discretionary m…

  11. Oct 13, 2026

    In progress

    UNH (UnitedHealth)Buy

    Positive conviction is maintained. The position is already open; no automatic add is executed.

  12. Oct 12, 2026

    In progress

    SMTCBuySatellite · Scanner

    The conviction remains positive, but the paper entry was rejected by quality, cost, or risk controls: no position was opened.

  13. Oct 8, 2026

    In progress

    PLTRBuySatellite · Scanner

    The conviction remains positive, but the paper entry was rejected by quality, cost, or risk controls: no position was opened.

  14. Oct 8, 2026

    In progress

    LINBuy

    Documentary review does not identify any admissible veto evidence because the frozen evidence bundle is empty. Accordingly, the quantitative engine’s immutable pullback plan remains unsuppressed; this review neither aut…

  15. Oct 8, 2026

    In progress

    COST (Costco)Buy

    Research posture is conditionally constructive solely because the deterministic engine has authorized the existing pullback template; this review neither authorizes nor modifies it. There is no initial tranche under tha…

  16. Oct 8, 2026

    In progress

    METABuy

    The conviction remains positive, but the paper entry was rejected by quality, cost, or risk controls: no position was opened.

  17. Oct 6, 2026

    In progress

    COST (Costco)Neutral

    The conviction remains positive, but the paper entry was rejected by quality, cost, or risk controls: no position was opened.

  18. Oct 6, 2026

    In progress

    LINNeutral

    The conviction remains positive, but the paper entry was rejected by quality, cost, or risk controls: no position was opened.

  19. Oct 6, 2026

    In progress

    METANeutral

    The trader is not opening a position right now (unconvincing setup, volume below recent average, elevated volatility).

  20. Oct 5, 2026

    In progress

    WBDBuySatellite · Scanner

    The conviction remains positive, but the paper entry was rejected by quality, cost, or risk controls: no position was opened.

  21. Oct 5, 2026

    In progress

    MSFT (Microsoft)Buy

    Positive conviction is maintained. The position is already open; no automatic add is executed.

  22. Sep 30, 2026

    In progress

    HIMSBuySatellite · Scanner

    The conviction remains positive, but the paper entry was rejected by quality, cost, or risk controls: no position was opened.

  23. Sep 30, 2026

    In progress

    HOODBuySatellite · Scanner

    The conviction remains positive, but the paper entry was rejected by quality, cost, or risk controls: no position was opened.

  24. Sep 30, 2026

    In progress

    EMRBuySatellite · Scanner

    The conviction remains positive, but the paper entry was rejected by quality, cost, or risk controls: no position was opened.

  25. Sep 30, 2026

    In progress

    NVDA (NVIDIA)Buy

    Positive conviction is maintained. The position is already open; no automatic add is executed.

  26. Sep 29, 2026

    In progress

    ASMLNeutralSatellite · Scanner

    The conviction remains positive, but the paper entry was rejected by quality, cost, or risk controls: no position was opened.

  27. Sep 29, 2026

    In progress

    LITENeutralSatellite · Scanner

    The conviction remains positive, but the paper entry was rejected by quality, cost, or risk controls: no position was opened.

  28. Sep 29, 2026

    In progress

    VTRSBuySatellite · Scanner

    The conviction remains positive, but the paper entry was rejected by quality, cost, or risk controls: no position was opened.

  29. Sep 29, 2026

    In progress

    XOM (Exxon Mobil)Buy

    Documentary review does not identify an admissible veto condition. The deterministic pullback plan remains the sole execution plan: no initial entry, with the existing trigger and risk parameters left unchanged. Researc…

  30. Sep 28, 2026

    In progress

    CRBGNeutralSatellite · Scanner

    The conviction remains positive, but the paper entry was rejected by quality, cost, or risk controls: no position was opened.

  31. Sep 28, 2026

    In progress

    VTRSBuySatellite · Scanner

    The conviction remains positive, but the paper entry was rejected by quality, cost, or risk controls: no position was opened.

  32. Sep 25, 2026

    In progress

    ARMNeutralSatellite · Scanner

    The conviction remains positive, but the paper entry was rejected by quality, cost, or risk controls: no position was opened.

  33. Sep 25, 2026

    In progress

    SMCIBuySatellite · Scanner

    The conviction remains positive, but the paper entry was rejected by quality, cost, or risk controls: no position was opened.

  34. Sep 25, 2026

    -1.6 %

    TWLONeutralSatellite · Scanner

    The conviction remains positive, but the paper entry was rejected by quality, cost, or risk controls: no position was opened.

  35. Sep 24, 2026

    In progress

    ARMNeutralSatellite · Scanner

    The conviction remains positive, but the paper entry was rejected by quality, cost, or risk controls: no position was opened.

  36. Sep 24, 2026

    -35.4 %

    NBISNeutralSatellite · Scanner

    The conviction remains positive, but the paper entry was rejected by quality, cost, or risk controls: no position was opened.

  37. Sep 23, 2026

    In progress

    SNXNeutralSatellite · Scanner

    The conviction remains positive, but the paper entry was rejected by quality, cost, or risk controls: no position was opened.

  38. Sep 22, 2026

    In progress

    STXNeutralSatellite · Scanner

    The conviction remains positive, but the paper entry was rejected by quality, cost, or risk controls: no position was opened.

  39. Sep 22, 2026

    In progress

    TWLOBuySatellite · Scanner

    The conviction remains positive, but the paper entry was rejected by quality, cost, or risk controls: no position was opened.

  40. Sep 21, 2026

    In progress

    ARMBuySatellite · Scanner

    The conviction remains positive, but the paper entry was rejected by quality, cost, or risk controls: no position was opened.

Recent completed sales

Recent paper executions, separate from new decisions.

  1. Paper sale executed

    PG (Procter & Gamble)
    Target reached

    Oct 22, 2026

    Entry price
    $145.33
    Exit price
    $164.69
    Quantity
    54
    Net return
    +13.2 %
  2. Paper sale executed

    MTSI
    Stop triggered

    Oct 15, 2026

    Entry price
    $299.64
    Exit price
    $275.39
    Quantity
    1
    Net return
    -8.2 %
  3. Paper sale executed

    WMT (Walmart)
    Target reached

    Oct 15, 2026

    Entry price
    $106.59
    Exit price
    $120.83
    Quantity
    74
    Net return
    +13.2 %
  4. Paper sale executed

    VLO
    Target reached

    Oct 8, 2026

    Entry price
    $378.98
    Exit price
    $430.57
    Quantity
    3
    Net return
    +13.5 %
  5. Paper sale executed

    XOM (Exxon Mobil)
    Thesis horizon reached

    Sep 29, 2026

    Entry price
    $160.02
    Exit price
    $161.31
    Quantity
    25
    Net return
    +0.7 %
  6. Paper sale executed

    AMZN (Amazon)
    Thesis horizon reached

    Sep 29, 2026

    Entry price
    $263.96
    Exit price
    $246.55
    Quantity
    7
    Net return
    -6.7 %
  7. Paper sale executed

    NVDA (NVIDIA)
    Thesis horizon reached

    Sep 29, 2026

    Entry price
    $218.97
    Exit price
    $227.10
    Quantity
    9
    Net return
    +3.6 %
  8. Paper sale executed

    MSFT (Microsoft)
    Thesis horizon reached

    Sep 28, 2026

    Entry price
    $505.58
    Exit price
    $508.97
    Quantity
    6
    Net return
    +0.6 %
  9. Paper sale executed

    AMD
    Target reached

    Sep 21, 2026

    Entry price
    $514.46
    Exit price
    $586.37
    Quantity
    2
    Net return
    +13.9 %
  10. Paper sale executed

    CVX (Chevron)
    Target reached

    Sep 2, 2026

    Entry price
    $200.08
    Exit price
    $211.89
    Quantity
    9
    Net return
    +5.8 %
  11. Paper sale executed

    NVDA (NVIDIA)
    Target reached

    Aug 28, 2026

    Entry price
    $222.86
    Exit price
    $225.89
    Quantity
    17
    Net return
    —